Kilitch Drugs India Ltd
Kilitch Drugs India Ltd (KILITCH) last traded at ₹173, a market capitalisation of ₹605 crore, on a P/E of 20.1. Over the past 52 weeks the stock has ranged between ₹117 and ₹220. Kilitch Drugs India Ltd last reported results for the quarter ended Jun 2026, with sales of ₹44.88 crore and net profit of ₹1.96 crore. Kilitch Drugs India Ltd’s annual general meeting is scheduled for 27 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.
Kilitch Drugs India Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Kilitch Drugs India Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹44.88 cr, up 4.0% from ₹43.14 cr a year earlier. Net profit was ₹1.96 cr, down 13.7% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 47.47 | 56.17 | 61.23 | 43.14 | 48.92 | 53.81 | 89.6 | 44.88 |
| Expenses | 41.37 | 47.44 | 46.64 | 39.88 | 43.88 | 47.66 | 67.46 | 41.94 |
| Operating profit | 6.1 | 8.73 | 14.59 | 3.26 | 5.04 | 6.15 | 22.14 | 2.94 |
| OPM % | 12.85% | 15.54% | 23.83% | 7.56% | 10.30% | 11.43% | 24.71% | 6.55% |
| Other income | 5.16 | 1.73 | 1.7 | 2.56 | 6.66 | 1.53 | 0.49 | 2.9 |
| Interest | 0.31 | 1.4 | 1.6 | 1.53 | 1.44 | 1.15 | 1.44 | 0.88 |
| Depreciation | 0.61 | 0.81 | 0.85 | 0.84 | 0.86 | 0.94 | 0.98 | 1.09 |
| Profit before tax | 10.34 | 8.25 | 13.84 | 3.45 | 9.4 | 5.59 | 20.21 | 3.87 |
| Tax % | 16.73% | 32.00% | 26.23% | 34.49% | 14.47% | 22.90% | 26.37% | 48.84% |
| Net profit | 8.61 | 5.61 | 10.22 | 2.27 | 8.04 | 4.31 | 14.88 | 1.96 |
| EPS (₹) | 2.46 | 1.70 | 2.97 | 0.87 | 2.34 | 1.27 | 4.15 | 0.83 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Kilitch Drugs India Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 68 | 114 | 140 | 154 | 198 | 235 | 237 |
| Operating profit | 5 | 10 | 18 | 24 | 32 | 37 | 36 |
| OPM % | 8% | 9% | 13% | 16% | 16% | 16% | 15% |
| Net profit | 4 | 6 | 8 | 14 | 25 | 30 | 29 |
| EPS (₹) | 1.09 | 2.17 | 3.08 | 4.17 | 7.63 | 8.63 | 8.59 |
TTM is the trailing twelve months to the most recent quarter.
Kilitch Drugs India Ltd growth and returns
- 10 Years
- 27%
- 5 Years
- 28%
- 3 Years
- 19%
- TTM
- 14%
- 10 Years
- 16%
- 5 Years
- 55%
- 3 Years
- 38%
- TTM
- 7%
- 10 Years
- 26%
- 5 Years
- 16%
- 3 Years
- 22%
- 1 Year
- -14%
- 10 Years
- 5%
- 5 Years
- 9%
- 3 Years
- 10%
- Last Year
- 11%
Kilitch Drugs India Ltd shareholding pattern
Promoters held 63.77% at Jun 2026, down from 69.23% at Jun 2025. FIIs 0.12%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 69.23% | 69.23% | 69.23% | 69.23% | 63.77% | 63.77% | 63.77% | 63.77% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.12% |
| Public | 30.77% | 30.76% | 30.77% | 30.77% | 36.22% | 36.23% | 36.22% | 36.11% |
| No. of shareholders | 9,920 | 10,139 | 9,749 | 10,379 | 10,929 | 12,043 | 11,785 | 12,627 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Kilitch Drugs India Ltd’s AGM?
Kilitch Drugs India Ltd’s annual general meeting is scheduled for 27 Aug 2026.
- AGM34th Annual General Meeting to transact business and review Annual Report for FY2025-26
See the full results calendar for every Indian company reporting in the next 30 days.
Kilitch Drugs India Ltd corporate filings
- We are submitting herewith the monitoring agency reportCompany Updatelow impact
Cruxal's analysis: Kilitch Drugs India Ltd has submitted its Monitoring Agency Report as per Regulation 30…
Read the full analysis - We are submitting herewith the publication of extract of the financial results for the quarter ended 30th June 2026Company Updatemedium impact
Cruxal's analysis: Kilitch Drugs (India) Ltd. has released its financial results for the quarter ended 30th…
Read the full analysis - We are submitting herewith the financial results for the quarter ended 30th June 2026Resulthigh impact
Cruxal's analysis: Kilitch Drugs (India) Ltd. reported a weak performance for the quarter ended 30th June…
Read the full analysis - Kilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve unaudited standalone and ....Board Meetinglow impact
Cruxal's analysis: Kilitch Drugs (India) Ltd. has formally intimated the stock exchanges regarding a Board…
Read the full analysis - We are submitting herewith the copy of the newspaper publication of extract of AGM NoticeCompany Updatelow impact
Cruxal's analysis: Kilitch Drugs (India) Ltd. has announced the newspaper publication on August 4, 2026…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Kilitch Drugs India Ltd
Cruxal reads every Kilitch Drugs India Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.